期刊文献+

3.0 T MR动态增强成像在前列腺癌诊断中的应用研究 被引量:6

3 T dynamic contrast-enhanced MRI diagnosis of prostate cancer
下载PDF
导出
摘要 目的探讨3.0 T MR动态增强成像(DCE-MRI)在前列腺癌诊断中的应用价值。方法收集疑诊前列腺癌者75例,所有患者均行T2WI和DCE-MRI检查。分析比较T2WI和DCE-MRI对前列腺癌诊断敏感性、特异性和准确性的差异,并分析DCE-MRI对前列腺癌的检出率和Gleason评分的相关性。结果前列腺癌患者44例,T2WI和DCE-MRI对前列腺癌诊断的敏感性、特异性和准确性分别为64%和91%、58%和77%、61%和85%。DCE-MRI诊断敏感性和准确性明显高于T2WI(P<0.01),而特异性未见明显高于T2WI(P>0.05)。DCE-MRI对高分化组Gleason评分<7分的前列腺癌检出率明显低于对中低分化组Gleason评分≥7分的前列腺癌(P<0.05)。结论和T2WI相比,3.0 T DCE-MRI能明显提高对前列腺癌的诊断敏感性和准确性。而且,DCE-MRI更容易检出中低分化的前列腺癌。 Objective To evaluate the diagnostic accuracy of 3 T dynamic contrast-enhanced MRI(DCE-MRI) for prostate cancer.Methods 75 patients with clinical suspicion of prostate cancer underwent T2-weighted MR imaging(T2WI) and DCEMRI.The sensitivity,specificity and accuracy of T2 WI and DCE-MRI for diagnosing prostate cancer were determined.The relationship between Gleason score and prostate cancer detection on DCE-MRI was also evaluated.Results Of 75 patients,prostate adenocarcinoma was confirmed histopathologically in 44.The sensitivity and accuracy of DCE-MRI(91%,85%) were significantly(P〈0.01) higher than those of T2WI(64%,61%).The specificity of DCE-MRI(77%) was not significantly(P〉0.05) higher than that of T2WI(58%).The detection rate for Gleason 4-6 cancers was significantly lower than that for Gleason 7-9 cancers(P〈0.05).Conclusion 3 T DCE-MRI is superior to T2 WI in prostate cancer detection and can detect more aggressive tumors.
出处 《影像诊断与介入放射学》 2014年第6期466-469,共4页 Diagnostic Imaging & Interventional Radiology
关键词 前列腺癌 T2加权成像 磁共振成像 动态增强 GLEASON评分 Prostate cancer T2 Weight imaging Magnetic resonance imaging Dynamic enhancement Gleason scale
  • 相关文献

参考文献6

二级参考文献73

共引文献66

同被引文献45

  • 1Center MM,Jemal A, Lortet-Tieulent J, et al. International varia tion in prostate cancer incidence and mortality rates[J]. Eur Urol, 2012,61 (2) : 1079-1092.
  • 2Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging[J]. Radiolo- gy, 2003,229 (1) : 248-254.
  • 3Alonzi R,Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate eancer[J]. Eur J Radiol,2007,63(3) :335-350.
  • 4Weidner A,Michaely HJ,Pelzer A,et al. Imaging of prostate can cer by diagnostic radiology and nuclear medicine [J]. Aktuelle Urol,2010,41(1) :35- 42.
  • 5Kim JK,Jang YJ,Cho G. Multidisciplinary functional MR imaging for prostate cancer[J]. Korean J Radiol,2009,10(6) : 535- 551.
  • 6Ren J, H uan Y, Wang H, et al. Dynamic contrast-enhanced MRi of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis[J]. Clin Radiol, 2008,63(2) : 153-159.
  • 7Schlemmer HP, Merkle J, Grobholz R, et al. Can preoperative con trast enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens[J]. Eur Radiol, 2004,14(3) : 309-317.
  • 8Jackson AS,Reinsberg SA,Sohaib SA, et al. Dynamic contrast- enhanced MRI for prostate cancer localization[J]. Br J Radiol, 2009,82(974) :148 -156.
  • 9Lowry M, Zelhof B, Liney GP, et al. Analysis of prostate DCE- MRI:comparison of fast exchange limit and fast exchange regi men pharmacokinetic models in the discrimination of malignant from normal tissue[J]. Invest Radiol, 2009,44 (9) : 577-584.
  • 10Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer:correlation on with morpholo gy and tumour stage, histological grade and PSA[J]. Clin Radiol, 2000,55(2) :99-109.

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部